Greg Piper (Just The News)
Governments and private entities are using a small rise in COVID-19 hospitalizations and new viral variants to juice interest in bivalent boosters that only 1 in 6 Americans have taken and to urge a return to routine masking, if not outright mandating new jabs and face coverings.
What they aren’t providing is robust evidence for the effectiveness of the interventions against infection by a virus that has already provided natural immunity to an estimated 19 in 20 Americans as of November 2022, according to Harvard research published in this month’s journal Clinical Infectious Diseases.